Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cardinal Health Inc    CAH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Cardinal Health to Buy Medical-Supplies Provider AssuraMed for $2.07 Billion

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/14/2013 | 02:08pm CET
   By Melodie Warner 
 

Cardinal Health Inc. (>> Cardinal Health, Inc.) agreed to acquire closely held medical-supplies provider AssuraMed for $2.07 billion as the drug wholesaler looks to diversify its offerings.

AssuraMed currently serves more than one million patients nationally with more than 30,000 products. The company bought Invacare Corp.'s (>> Invacare Corporation) domestic medical supplies business for $150 million last month. Including that business, Cardinal Heath said AssuraMed had 2012 revenue of $1 billion.

After the transaction is complete, Cardinal Health will supply ostomy, diabetes, insulin therapy, urological, wound care and incontinence products to the home-healthcare market.

"This is a platform opportunity for Cardinal Health products and services which will be increasingly important as the delivery of care migrates to more cost-effective settings," said Chairman and Chief Executive George Barrett.

Cardinal Health expects AssuraMed to add two cents to three cents a share to its fiscal 2013 adjusted earnings, assuming the deal closes by early April.

The company also estimates its will boost fiscal 2014 adjusted earnings by at least 18 cents a share.

Cardinal has previously disclosed the loss of its contract with pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) to rival AmerisourceBergen Corp. (>> AmerisourceBergen Corp.). Two of Cardinal's huge drug-distribution customers, Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation), have contracts set to end this summer.

The company earlier this month reported its fiscal second-quarter earnings rose 16% as improved margins helped to offset weaker revenue at its pharmaceutical division, which was caused partly by generic-drug introductions.

Shares closed Wednesday at $45.44 and were inactive premarket. The stock has risen 8% over the past year.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CARDINAL HEALTH INC
02/15 CARDINAL HEALTH : Survey Finds Hospital Staff Report Better Supply Chain Managem..
02/15 Fibrin Sealant Market 2017 - Adhezion Biomedical, Hemostasis, Arch Therapeuti..
02/14 INSIDER TRADING ACTIVITY CARDINAL HE : CAH) – Chairman Sold 217,994 shares..
02/14 CARDINAL HEALTH : City of Welch suing drug companies over opioids
02/09 CARDINAL HEALTH : profits remain flat but CEO sees potential relief in generic p..
02/07DJCARDINAL HEALTH : Again Trims 2017 Profit Forecast
02/07 CARDINAL HEALTH : beats 2Q profit forecasts
02/07 CARDINAL HEALTH : Reports Second-quarter Results for Fiscal Year 2017
02/07 CARDINAL HEALTH INC : Results of Operations and Financial Condition (form 8-K)
02/05 CARDINAL HEALTH : Drug Distributors Penalized For Turning Blind Eye In Opioid Ep..
More news
Sector news : Drug Retailers - NEC
02/16DJRetail CEOs Meet With Trump Over Border Tax Concerns -- Update
02/15DJRetail CEOs Meet With Trump Over Border Tax Concerns
02/14DJEXPRESS SCRIPTS : Revenue Falls
02/14 Exclusive - Trump to meet with retail CEOs on taxes, infrastructure
02/09DJCVS HEALTH : Profit Rises, Helped by Pharmacy Strength -- Update
More sector news : Drug Retailers - NEC
News from SeekingAlpha
02/22 Buying McKesson At A 10% Yield
02/16 Tracking Seth Klarman's Baupost Group Holdings - Q4 2016 Update
02/15 THE MNM PORTFOLIO, JAN. 2017 : Ep. 23 - Introducing The MnM 401K!
02/13 MY 86 STOCK PORTFOLIO EVALUATION : Is The Price Right To Buy Using A 3 Category ..
02/12 Some Green Ideas For Extra Green
Advertisement
Financials ($)
Sales 2017 130 915 M
EBIT 2017 2 872 M
Net income 2017 1 377 M
Debt 2017 2 904 M
Yield 2017 2,20%
P/E ratio 2017 18,47
P/E ratio 2018 15,87
EV / Sales 2017 0,22x
EV / Sales 2018 0,20x
Capitalization 25 659 M
More Financials
Chart CARDINAL HEALTH INC
Duration : Period :
Cardinal Health Inc Technical Analysis Chart | CAH | US14149Y1082 | 4-Traders
Full-screen chart
Technical analysis trends CARDINAL HEALTH INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 82,0 $
Spread / Average Target 0,81%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
George S. Barrett Chairman & Chief Executive Officer
Michael C. Kaufmann Chief Financial Officer
Patricia B. Morrison Chief Information Officer & EVP
Calvin Ramarro Darden Independent Director
Gregory B. Kenny Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CARDINAL HEALTH INC13.02%25 659
WALGREENS BOOTS ALLIAN..4.41%93 272
CVS HEALTH CORP1.08%81 810
EXPRESS SCRIPTS HOLDIN..2.82%43 230
MCKESSON CORPORATION7.43%31 997
AMERISOURCEBERGEN CORP..16.82%19 775
More Results